Session # 113

Germline Mutation Prevalence in Consecutive, Unselected Individuals with Pancreatic Adenocarcinoma 

  • The prevalence of germline mutations in unselected patients with pancreatic ductal adenocarcinoma was found to be 12% in this study.
  • Prior studies investigating mutation prevalence have provided estimates of prevalence but have primarily been carried out on selected groups of pancreatic cancer patients.

Search Results

Start your search...